Nevertheless, although the activation of NK and effector T cells by IL-21-MSC treatment reduced tumour progression and improved survival in transplanted mice, no significant anticancer responses were observed following the injection of MSCs with recombinant adenovirus-expressing IL-21 (rAD/IL-21) in the mice (55). The gene discussed is IL21; the disease is neoplasm.